Fig. 5
From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Correlations of the immune score, stromal score, and ESTIMATE scores with METTL7B expression in the top three cancers. A SARC. B LGG. C PARD
Fig. 5 | Cancer Cell International